GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Comedian Amy Schumer shared that she is on a new weight loss drug after experiencing severe side effects from Ozempic. Amy Schumer/Instagram “They put me on estrogen and progesterone because I ...

Long-term hair loss seems to be more unlikely, the doctor said, as the “inciting event” (weight loss and stress) often normalizes as individuals reach their target weight. Potential limitations ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Amy Schumer revealed she’s on a new weight loss medication after her last attempt on the drugs left her so nauseous she couldn’t lift her head off the pillow. “Mounjaro’s been great ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

Explore real AquaSculpt reviews, personal experiences, and whether this supplement delivers on its promises for fat ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

Amy Schumer revealed she’s on a new weight loss medication after her last attempt on the drugs left her so nauseous she couldn’t lift her head off the pillow. “Mounjaro’s been great ...

Amy Schumer's experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication years ago. Schumer, 43, praised the effects of Mounjaro (also known as ...